| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30008556 | HIV | ENSG00000109618.13 | protein_coding | SEPSECS | No | No | 51091 | A1A4F3 Q9HD40 |
| TVIS30078425 | HIV | ENSG00000109618.13 | protein_coding | SEPSECS | No | No | 51091 | A1A4F3 Q9HD40 |
| TVIS30059747 | HIV | ENSG00000109618.13 | protein_coding | SEPSECS | No | No | 51091 | A1A4F3 Q9HD40 |
| TVIS30059748 | HIV | ENSG00000109618.13 | protein_coding | SEPSECS | No | No | 51091 | A1A4F3 Q9HD40 |
| TVIS44025289 | HTLV-1 | ENSG00000109618.13 | protein_coding | SEPSECS | No | No | 51091 | A1A4F3 Q9HD40 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SEPSECS |
|---|---|
| DrugBank ID | DB00114 |
| Drug Name | Pyridoxal phosphate |
| Target ID | BE0002171 |
| UniProt ID | Q9HD40 |
| Regulation Type | cofactor |
| PubMed IDs | 17194211; 11481605 |
| Citations | Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ, Gladyshev VN, Hatfield DL: Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2007 Jan;5(1):e4.@@Kernebeck T, Lohse AW, Grotzinger J: A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology. 2001 Aug;34(2):230-3. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Pyridoxals and derivatives |
| SMILES | CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O |
| Pathways | Histidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling |
| PharmGKB | PA164749650 |
| ChEMBL | CHEMBL82202 |
